ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET 2022-2028

$1,500

A report by CRI depicts that the cardiovascular ultrasound market in the Asia-Pacific will advance with a CAGR of 6.83% over the projected duration between 2022 and 2028.

SKU: TR-78-2019 Category: Tag:

Description

MARKET OUTLOOK

A report by CRI depicts that the cardiovascular ultrasound market in the Asia-Pacific will advance with a CAGR of 6.83% over the projected duration between 2022 and 2028. India, Japan, China, Australia & New Zealand, ASEAN countries, South Korea, and Rest of Asia-Pacific are evaluated in the market in this region.
Since the past two decades, the number of patients suffering from heart failure in Japan has grown rapidly, and has become a crucial issue in the fields of medical practice and public health. As a result, the demand for electrocardiography devices to detect cardiovascular diseases on time has increased. Also, manufacturers are focusing on incorporating advanced technologies into ultrasound machines. These factors are fueling the studied market’s growth in Japan.
In India, non-communicable diseases, such as cardiovascular disease (CVD), cancer, and others, account for nearly 60% of all deaths. In fact, CVDs are now the leading cause of death among Indians. Some factors associated with the cardiovascular disease epidemic in the nation are particularly alarming, such as its rapid spread, disease onset at a young age, and the high mortality rate. Cardiovascular ultrasound machines are thus witnessing high demand. Key players like Siemens Healthineers, Philips Healthcare, and others, are offering their products to meet the rising needs of the healthcare sector and to aid in timely disease detection & treatment. This, in turn, is expected to drive the market growth in the long run.

COMPETITIVE OUTLOOK

Some of the acclaimed players in the cardiovascular ultrasound market are Canon Medical Corp, Telemed Ultrasound Medical Systems, Samsung Medison Co Ltd, Lanmage, Esaote S.p.A., Dawei Medical, Siemens Healthineers, and Mindray Medical International Limited.

TABLE OF CONTENTS

1. ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET – SUMMARY
2. INDUSTRY OUTLOOK
2.1. IMPACT OF COVID-19 ON THE CARDIOVASCULAR ULTRASOUND MARKET
2.2. KEY INSIGHTS
2.2.1. EMERGENCE OF ARTIFICIAL INTELLIGENCE (AI)
2.2.2. STRAIN IMAGING HAS SEEN A GRADUAL INCREASE
2.3. PORTER’S FIVE FORCES ANALYSIS
2.3.1. THREAT OF NEW ENTRANTS
2.3.2. THREAT OF SUBSTITUTES
2.3.3. BARGAINING POWER OF BUYERS
2.3.4. BARGAINING POWER OF SUPPLIERS
2.3.5. THREAT OF COMPETITIVE RIVALRY
2.4. KEY IMPACT ANALYSIS
2.4.1. QUALITY
2.4.2. DURABILITY
2.4.3. PRICE
2.4.4. TECHNOLOGY
2.5. MARKET ATTRACTIVENESS INDEX
2.6. VENDOR SCORECARD
2.7. INDUSTRY COMPONENTS
2.8. REGULATORY FRAMEWORK
2.9. KEY MARKET STRATEGIES
2.9.1. PRODUCT LAUNCHES
2.9.2. ALLIANCES
2.10. MARKET DRIVERS
2.10.1. INCREASE IN CARDIOVASCULAR DISEASE CASES
2.10.2. ADVANCEMENTS IN TECHNOLOGY
2.11. MARKET CHALLENGES
2.11.1. LACK OF AWARENESS AMONG PATIENTS
2.11.2. NEED TO ABIDE BY STRINGENT REGULATIONS
2.12. MARKET OPPORTUNITIES
2.12.1. RAPID EXPANSION OF POINT-OF-CARE ULTRASOUND (POCUS)
2.12.2. GROWING CARDIOVASCULAR ULTRASOUND MARKET IN THE ASIA-PACIFIC REGION
2.12.3. RAPID GROWTH OF FETAL ECHOCARDIOGRAPHY
3. ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET OUTLOOK – BY DISPLAY
3.1. BLACK AND WHITE
3.2. COLORED
4. ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET OUTLOOK – BY TECHNOLOGY
4.1. 2D
4.2. 3D/4D
4.3. DOPPLER
5. ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET OUTLOOK – BY TYPE
5.1. TRANSTHORACIC ECHOCARDIOGRAPHY
5.2. FETAL ECHOCARDIOGRAPHY
5.3. TRANSESOPHAGEAL ECHOCARDIOGRAPHY
5.4. OTHER TYPES
6. ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET OUTLOOK – BY END-USER
6.1. HOSPITALS
6.2. DIAGNOSTIC CENTERS
6.3. AMBULATORY CARE CENTERS
6.4. OTHER END-USERS
7. ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET – COUNTRY OUTLOOK
7.1. CHINA
7.2. JAPAN
7.3. INDIA
7.4. SOUTH KOREA
7.5. ASEAN COUNTRIES
7.6. AUSTRALIA & NEW ZEALAND
7.7. REST OF ASIA-PACIFIC
8. COMPETITIVE LANDSCAPE
8.1. GE HEALTHCARE
8.2. PHILIPS HEALTHCARE
8.3. SIEMENS HEALTHINEERS
8.4. CANON MEDICAL CORP
8.5. FUJIFILM HOLDINGS CORPORATION
8.6. SAMSUNG MEDISON CO LTD
8.7. ESAOTE S.P.A.
8.8. MINDRAY MEDICAL INTERNATIONAL LIMITED
8.9. VIATOM TECHNOLOGY CO
8.10. LANMAGE
8.11. DAWEI MEDICAL
8.12. ZONCARE
8.13. LELTEK INC
8.14. TELEMED ULTRASOUND MEDICAL SYSTEMS
8.15. CLARIUS
9. RESEARCH METHODOLOGY & SCOPE
9.1. RESEARCH SCOPE & DELIVERABLES
9.2. SOURCES OF DATA
9.3. RESEARCH METHODOLOGY

TABLE LIST

TABLE 1: ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET, BY COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 2: VENDOR SCORECARD
TABLE 3: LIST OF PRODUCT LAUNCHES
TABLE 4: LIST OF ALLIANCES
TABLE 5: ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET, BY COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 6: ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET, BY DISPLAY, 2022-2028 (IN $ MILLION)
TABLE 7: ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET, BY TECHNOLOGY, 2022-2028 (IN $ MILLION)
TABLE 8: ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET, BY TYPE, 2022-2028 (IN $ MILLION)
TABLE 9: ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET, BY END-USER, 2022-2028 (IN $ MILLION)

FIGURE LIST

FIGURE 1: KEY BUYING IMPACT ANALYSIS
FIGURE 2: MARKET ATTRACTIVENESS INDEX
FIGURE 3: INDUSTRY COMPONENTS
FIGURE 4: ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET, BY DISPLAY, 2021 & 2028 (IN %)
FIGURE 5: ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET, BY BLACK AND WHITE, 2022-2028 (IN $ MILLION)
FIGURE 6: ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET, BY COLORED, 2022-2028 (IN $ MILLION)
FIGURE 7: ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET, BY TECHNOLOGY, 2021 & 2028 (IN %)
FIGURE 8: ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET, BY 2D, 2022-2028 (IN $ MILLION)
FIGURE 9: ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET, BY 3D/4D, 2022-2028 (IN $ MILLION)
FIGURE 10: ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET, BY DOPPLER, 2022-2028 (IN $ MILLION)
FIGURE 11: ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET, BY TYPE, 2021 & 2028 (IN %)
FIGURE 12: ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET, BY TRANSTHORACIC ECHOCARDIOGRAPHY, 2022-2028 (IN $ MILLION)
FIGURE 13: ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET, BY FETAL ECHOCARDIOGRAPHY, 2022-2028 (IN $ MILLION)
FIGURE 14: ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET, BY TRANSESOPHAGEAL ECHOCARDIOGRAPHY, 2022-2028 (IN $ MILLION)
FIGURE 15: ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET, BY OTHER TYPES, 2022-2028 (IN $ MILLION)
FIGURE 16: ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET, BY END-USER, 2021 & 2028 (IN %)
FIGURE 17: ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET, BY HOSPITALS, 2022-2028 (IN $ MILLION)
FIGURE 18: ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET, BY DIAGNOSTIC CENTERS, 2022-2028 (IN $ MILLION)
FIGURE 19: ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET, BY AMBULATORY CARE CENTERS, 2022-2028 (IN $ MILLION)
FIGURE 20: ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET, BY OTHER END-USERS, 2022-2028 (IN $ MILLION)
FIGURE 21: ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET, COUNTRY OUTLOOK, 2021 & 2028 (IN %)
FIGURE 22: CHINA CARDIOVASCULAR ULTRASOUND MARKET 2022-2028 (IN $ MILLION)
FIGURE 23: JAPAN CARDIOVASCULAR ULTRASOUND MARKET 2022-2028 (IN $ MILLION)
FIGURE 24: INDIA CARDIOVASCULAR ULTRASOUND MARKET 2022-2028 (IN $ MILLION)
FIGURE 25: SOUTH KOREA CARDIOVASCULAR ULTRASOUND MARKET 2022-2028 (IN $ MILLION)
FIGURE 26: ASEAN COUNTRIES CARDIOVASCULAR ULTRASOUND MARKET 2022-2028 (IN $ MILLION)
FIGURE 27: AUSTRALIA & NEW ZEALAND CARDIOVASCULAR ULTRASOUND MARKET 2022-2028 (IN $ MILLION)
FIGURE 28: REST OF ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET 2022-2028 (IN $ MILLION)

Additional information

Publisher

Date Published

Pages

Format

Companies Mentioned

1. GE HEALTHCARE
2. PHILIPS HEALTHCARE
3. SIEMENS HEALTHINEERS
4. CANON MEDICAL CORP
5. FUJIFILM HOLDINGS CORPORATION
6. SAMSUNG MEDISON CO LTD
7. ESAOTE S.P.A.
8. MINDRAY MEDICAL INTERNATIONAL LIMITED
9. VIATOM TECHNOLOGY CO
10. LANMAGE
11. DAWEI MEDICAL
12. ZONCARE
13. LELTEK INC
14. TELEMED ULTRASOUND MEDICAL SYSTEMS
15. CLARIUS

Reviews

There are no reviews yet.

Be the first to review “ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET 2022-2028”